retatrutide trials in boston 💉 may be redefining obesity treatment. New data from TRIUMPH-1 Trial showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Eli Lilly Preparing Retatrutide Applications

But wait, theres more

Jakubek Y, Lang W, Vattathil S, Garcia M, Xu L, Huang L, Yoo SY, Shen L, Lu W, Chow CW, Weber Z, Davies G, Huang J, Behrens C, Kalhor N, Moran C, Fujimoto J, Mehran R, El-Zein R, Swisher SG , Wang J, Fowler J, Spira AE, Ehli EA, Wistuba II, Scheet P, Kadara H

747 Fer-1 analog Srs11-92 (AA9) ameliorates oxidative stress and ferroptosis through Nrf2 signaling, and improves cerebral infarction size, neuronal injury, and neural function deficit in MCAO/R model mice

4 Naveed, Maneeha

doi:10.2165/00023210-200216110-00002

This process is key to energy metabolism and is often mentioned in contexts of physical activity, especially when energy demand increases